Advertisement

Topics

Centrexion Therapeutics Company Profile

18:23 EST 19th January 2017 | BioPortfolio

Centrexion Therapeutics, Inc., is focused on developing and commercializing new, non-opioid and non-surgical treatments for moderate to severe chronic pain. Centrexion Therapeutics recognizes the needs of over a quarter of a billion patients living with chronic pain worldwide, and aims to develop new, safer and more effective therapies that overcome the limitations and challenges associated with current pain treatments. Founded by world-renowned leaders in drug development and well-funded by key investors, Centrexion Therapeutics is building a pain treatment powerhouse to address the substantial and growing global problem of chronic pain.


News Articles [1866 Associated News Articles listed on BioPortfolio]

FDA fast-tracks Centrexion's Morton's neuroma treatment

Centrexion Therapeutics' CNTX-4975 received fast-track status from the FDA as a treatment for Morton's neuroma, a rare pain d -More- 

BRIEF-Centrexion Therapeutics announces fast track designation granted by FDA to cntx-4975

* Centrexion Therapeutics announces fast track designation granted by FDA to CNTX-4975 for treatment of Morton's Neuroma Source text for Eikon:

Centrexion's pain candidate passes Phase IIb test

Centrexion Therapeutics Corp. (Boston, Mass.) said pain candidate CNTX-4975 met the primary endpoint in a Phase IIb study to treat osteoarthritis (OA) knee pain. Compared with placebo, each of two tes...

Centrexion Therapeutics announces results from study on injection for relief of OA knee pain

Centrexion Therapeutics announced positive data from its phase 2b study of patients with knee osteoarthritis pain treated with CNTX-4975, the company’s lead pipeline candidate for pain reduction. Ac...

Centrexion Therapeutics Announces Highly Statistically Significant Topline Results from Phase ...

Pain Relief Occurred within Days, Lasted At Least Six Months from Single Injection Read more...

Centrexion's Touts Success of Phase IIb Study for Knee Osteoarthritis Pain

  Life Sciences Jobs   ...

Centrexion Touts Success of Phase IIb Study for Knee Osteoarthritis Pain

  Life Sciences Jobs   ...

Centrexion osteoarthritis drug hits its mark in Phase 2

The announcement closes out an active year for the company, which has been working to establish itself in the pain medication space.

Drugs and Medications [0 Results]

None

Clinical Trials [18 Associated Clinical Trials listed on BioPortfolio]

A Trial to Find Safe and Active Doses of an Investigational Drug CX-072 for Patients With Solid Tumors or Lymphomas

The purpose of this first-in-human study of CX-072 is to characterize the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and antitumor activity of CX-072 administered i...

Beat AML Core Study

In this study, DNA sequencing, computational biology modeling, and ex vivo drug sensitivity assays will be utilized to define clinically relevant gene mutations and identify potential ther...

Localized Therapeutics for the Treatment of Gastrointestinal Disorders II

The purpose of this study is to investigate a novel thermosensitive topical gel formulation for the treatment of inflammatory bowel disease (IBD), specifically ulcerative colitis.

Amnis Therapeutics Thrombectomy Device-First in Man (FIM) Safety and Performance Study

Prospective, single-arm, open label, Safety and Performance clinical investigation.

A Gene Transfer Study for Hemophilia A

This clinical research study is being conducted by Spark Therapeutics, Inc. to determine the safety and efficacy of the factor VIII gene transfer treatment with SPK-8011 in individuals wit...

Companies [7 Associated Companies listed on BioPortfolio]

Centrexion Therapeutics

Centrexion Therapeutics, Inc., is focused on developing and commercializing new, non-opioid and non-surgical treatments for moderate to severe chronic pain. Centrexion Therapeutic...

Antegrin Therapeutics, Inc.

Antegrin Therapeutics, Inc., is a pharmaceutical company dedicated to developing novel treatments for fibrotic diseases. The company aims to select its first clinical development ...

Constance Therapeutics

Constance Therapeutics is a vertically integrated medicinal cannabis company producing standardized and science-based whole plant cannabis extracts. The company has created a new ...

venBio Select Advisor LLC

venBio Select Advisor LLC (“venBio Select”) is the SEC registered investment manager for venBio’s public markets strategy and its main equity investment vehicle â...

Cambrooke Therapeutics, Inc.

Founded in 2000, Cambrooke is a private equity-backed, Massachusetts-based therapeutic nutrition company and global provider of medical nutrition products for patients with seriou...

More Information about "Centrexion Therapeutics" on BioPortfolio

We have published hundreds of Centrexion Therapeutics news stories on BioPortfolio along with dozens of Centrexion Therapeutics Clinical Trials and PubMed Articles about Centrexion Therapeutics for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Centrexion Therapeutics Companies in our database. You can also find out about relevant Centrexion Therapeutics Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Pain Disorder
Pain is a feeling (sharp or dull) triggered in the nervous system which can be transient or constant. Pain can be specific to one area of the body eg back, abdomen or chest or more general all over the body eg muscles ache from the flu. Without pain ...

Pain
Pain is defined by the International Association for the Study of Pain as “an unpleasant sensory and emotional experience associated with actual or potential tissue damage or described in terms of such damage”. Some illnesses can be excruci...


Corporate Database Quicklinks



Searches Linking to this Company Record